Ovulation induction treatment and risk of borderline ovarian tumors

Gynecological Endocrinology

Volumn 23, Issue 7, 2007, Pages 373-376

  Cusidó, Maite ^a,b   Fábregas, Rafael ^a   Pere, Barris S ^a   Escayola, Cecilia ^a   Barri, Pere Nolsac ^a  

^a INSTITUT UNIVERSITARI DEXEUS   (Spain)

^b NONE   (Spain)

Author keywords

Borderline ovarian tumors; Fertility drugs; Infertility; Ovarian cancer

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN;

ABSENCE OF SIDE EFFECTS; ADULT; ANALYTIC METHOD; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HUMAN; INFERTILITY THERAPY; MULTIPLE CYCLE TREATMENT; OVARY TUMOR; OVULATION; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPINS; HUMANS; NEOPLASMS; OVARIAN NEOPLASMS; OVULATION INDUCTION; RETROSPECTIVE STUDIES;

EID: 34548126131     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590701350341     Document Type: Article

References (17)

1. Whittemore AS. The risk of ovarian cancer after treatment for infertility. N Engl J Med 1994;331:805-806.
2. Fathalla MF. Incessant ovulation: a factor in ovarian neoplasia? Lancet 1971;2:163.
3. La Vecchia C, Decarli A, Franceschi S, Regallo M, Tognoni G. Age at first birth and the risk of epithelial ovarian cancer. J Natl Cancer Inst 1984;73:663-666.
4. Whittemore AS, Harris R, Itnyre J. Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992;136:1184-1203.
5. Harris R, Whittemore AS, Itnyre J. Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case control studies. III. Epithelial tumors of low malignant potential in white women. Am J Epidemiol 1992;136:1204-1211.
6. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-776.
7. Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN. Ovarian stimulation and borderline ovarian tumors: a case-control study. Fertil Steril 1998;70:1049-1055.
8. Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, Purdie DM, Risch HA, Vergona R, Wu AH. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002;155:217-224.
9. Balasch J, Barri PN. Follicular stimulation and ovarian cancer? Human Reprod 1993;8:990-996.
10. Del Priore G, Robischon K, Phipps WR. Risk of ovarian cancer after treatment for infertility. N Engl J Med 1995;332:1300-2.
11. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996;65:13-18.
12. Saygili U, Uslu T, Erten O, Dogan E. Borderline ovarian tumors: retrospective analysis of twenty-one cases. Eur J Gynaecol Oncol 1998;19:182-185.
13. Goldberg GL, Runowicz. Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation. Is there a link? Am J Obstet Gynecol 1992;166:853-854.
14. Parazzini F, Negri E, La Vecchia C, Moroni S, Polatti A, Chiaffarino F, Surace M, Ricci E. Treatment for fertility and risk of ovarian tumors of borderline malignancy. Gynecol Oncol 1998;68:226-228.
15. Venn A, Healy D, McLachlan R. Cancer risks associated with the diagnosis of infertility. Best Practice Res Clin Obstet Gynaecol 2003;17:343-367.
16. Mosgaard B, Lidegaard O, Kjaer SK, Schou G, Andersen AN. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1997;67:1005-1012.
17. Cusidó M, Sas A, Tresserra F, Grases P, Labastiba R. Tumor epitelial limitrofe (borderline) del ovario: estudio de 33 casos. Prog Obstet Ginecol 1999;42:447-53.